Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies

Gelijkaardige items

• Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
  door: Bangs, Mark E., et al.
  Gepubliceerd in: (2020)
• A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
  door: Camporeale, Angelo, et al.
  Gepubliceerd in: (2018)
• Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine
  door: Stauffer, Virginia L., et al.
  Gepubliceerd in: (2020)
• Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
  door: Ford, Janet H., et al.
  Gepubliceerd in: (2020)
• Galcanezumab for migraine
  Gepubliceerd in: (2020)